Growth Metrics

Boston Scientific (BSX) Total Debt Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 157.11%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -12.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 5.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -2.48%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.12%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.70%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 15.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -5.48%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 4.11%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.48%
Dec 31, 2025 6.42%
Sep 30, 2025 6.57%
Jun 30, 2025 9.61%
Mar 31, 2025 6.50%
Dec 31, 2024 18.06%
Sep 30, 2024 22.32%
Jun 30, 2024 16.77%
Mar 31, 2024 17.92%
Dec 31, 2023 1.87%
Sep 30, 2023 3.67%
Jun 30, 2023 0.90%
Mar 31, 2023 -3.22%
Dec 31, 2022 -1.43%
Sep 30, 2022 -5.51%
Jun 30, 2022 -1.50%
Mar 31, 2022 2.31%
Dec 31, 2021 -0.85%
Sep 30, 2021 19,229.79%
Jun 30, 2021 28,365.63%
Mar 31, 2021 45,375.00%
Dec 31, 2020 -8.64%
Sep 30, 2020 -99.57%
Jun 30, 2020 -99.66%
Mar 31, 2020 -99.78%
Dec 31, 2019 41.84%
Sep 30, 2019 64.31%
Jun 30, 2019 46.93%
Mar 31, 2019 60.07%
Dec 31, 2018 25.64%
Sep 30, 2018 16.61%
Jun 30, 2018 11.28%
Mar 31, 2018 4.55%
Dec 31, 2017 2.41%
Sep 30, 2017 4.74%
Jun 30, 2017 7.52%
Mar 31, 2017 -2.87%
Dec 31, 2016 -3.40%
Sep 30, 2016 -7.41%
Jun 30, 2016 6.16%
Mar 31, 2016 33.01%
Dec 31, 2015 33.77%
Sep 30, 2015 37.79%
Jun 30, 2015 20.14%
Mar 31, 2015 0.45%
Dec 31, 2014 0.09%
Sep 30, 2014 0.07%
Jun 30, 2014 0.07%
Mar 31, 2014 -0.12%
Dec 31, 2013 -0.38%
Sep 30, 2013 -0.14%
Jun 30, 2013 -0.12%
Mar 31, 2013 -0.12%
Dec 31, 2012 -0.12%
Sep 30, 2012 -0.19%
Jun 30, 2012 1.33%
Mar 31, 2012 -13.51%
Dec 31, 2011 -21.64%
Sep 30, 2011 -29.39%
Jun 30, 2011 -30.37%
Mar 31, 2011 -16.84%
Dec 31, 2010 -8.11%
Sep 30, 2010 0.12%
Jun 30, 2010 -3.47%